Search

Author/Creator Nesheiwat, T

1. B05: RESULTS FROM A META-ANALYSIS OF CILTACABTAGENE AUTOLEUCEL COMPARED TO PHYSICIAN'S CHOICE OF TREATMENT IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA. (5th April 2022)

Authors:
Gay, F; Berdeja, JG; De Stefano, V; Hari, P; Hooper, B; Haltner, A; Kumar, S; Martin, T; Mateos, M-V; Moreau, P; Rosta, E; Samjoo, IA; Usmani, SZ; Weisel, K; Jackson, CC; Olyslager, Y; Schecter, JM; Vogel, M; Garrett, A; Lee, S
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 2
Page Start:
8
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. B07: SAFETY AND EFFICACY OF CILTACABTAGENE AUTOLEUCEL, A CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY DIRECTED AGAINST B-CELL MATURATION ANTIGEN IN PATIENTS WITH MULTIPLE MYELOMA AND EARLY RELAPSE AFTER INITIAL THERAPY: CARTITUDE-2 RESULTS. (5th April 2022)

Authors:
van de Donk, NWCJ; Delforge, M; Agha, M; Cohen, AD; Cohen, YC; Hillengass, J; Anguille, S; Kerre, T; Roeloffzen, W; Schecter, JM; De Braganca, KC; Varsos, H; Wang, L; Vogel, M; Zudaire, E; Corsale, C; Akram, M; Geng, D; Nesheiwat, T; Pacaud, L
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 2
Page Start:
9
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. P08: CARTITUDE-2 UPDATE: CILTACABTAGENE AUTOLEUCEL, A B-CELL MATURATION ANTIGEN–DIRECTED CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY, IN LENALIDOMIDE-REFRACTORY PATIENTS WITH PROGRESSIVE MULTIPLE MYELOMA AFTER 1-3 PRIOR LINES OF THERAPY. (5th April 2022)

Authors:
Einsele, H; Cohen, AD; Delforge, M; Hillengass, J; Goldschmidt, H; Weisel, K; Raab, M-S; Scheid, C; Schecter, JM; De Braganca, KC; Varsos, H; Yeh, T-M; Wang, L; Vogel, M; Corsale, C; Akram, M; Pacaud, L; Nesheiwat, T; Agha, M; Cohen, YC
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 2
Page Start:
15
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. S185: CARTITUDE-2 COHORT B: UPDATED CLINICAL DATA AND BIOLOGICAL CORRELATIVE ANALYSES OF CILTACABTAGENE AUTOLEUCEL IN PATIENTS WITH MULTIPLE MYELOMA AND EARLY RELAPSE AFTER INITIAL THERAPY. (23rd June 2022)

Authors:
Agha, M. E.; van de Donk, N. W.; Cohen, A. D.; Cohen, Y. C.; Anguille, S.; Kerre, T.; Roeloffzen, W.; Schecter, J. M.; De Braganca, K. C.; Varsos, H.; Mistry, P.; Roccia, T.; Zudaire, E.; Corsale, C.; Akram, M.; Geng, D.; Nesheiwat, T; Pacaud, L.; Sonneveld, P.; Zweegman, S.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
86
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search